Miracle Mile Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,000
| Closed | -$69K | – | 746 |
|
|
2025
Q1 | $69K | Hold |
10,000
| – | – | ﹤0.01% | 635 |
|
|
2024
Q4 | $53.1K | Hold |
10,000
| – | – | ﹤0.01% | 625 |
|
|
2024
Q3 | $36.5K | Hold |
10,000
| – | – | ﹤0.01% | 520 |
|
|
2024
Q2 | $27.3K | Buy |
+10,000
| New | +$27.3K | ﹤0.01% | 497 |
|
|
2021
Q4 | – | Sell |
-21,000
| Closed | -$132K | – | 486 |
|
|
2021
Q3 | $132K | Buy |
21,000
+2,000
| +11% | +$12.6K | 0.01% | 408 |
|
|
2021
Q2 | $187K | Hold |
19,000
| – | – | 0.01% | 364 |
|
|
2021
Q1 | $177K | Sell |
19,000
-1,000
| -5% | -$9.32K | 0.01% | 361 |
|
|
2020
Q4 | $96K | Sell |
20,000
-11,000
| -35% | -$52.8K | 0.01% | 361 |
|
|
2020
Q3 | $124K | Sell |
31,000
-10,000
| -24% | -$40K | 0.01% | 341 |
|
|
2020
Q2 | $188K | Sell |
41,000
-25,000
| -38% | -$115K | 0.02% | 290 |
|
|
2020
Q1 | $215K | Hold |
66,000
| – | – | 0.02% | 252 |
|
|
2019
Q4 | $284K | Buy |
66,000
+6,000
| +10% | +$25.8K | 0.02% | 246 |
|
|
2019
Q3 | $236K | Sell |
60,000
-5,000
| -8% | -$19.7K | 0.02% | 254 |
|
|
2019
Q2 | $302K | Hold |
65,000
| – | – | 0.02% | 219 |
|
|
2019
Q1 | $272K | Buy |
+65,000
| New | +$272K | 0.02% | 225 |
|